PCI Pharmaceutical Consulting

Size: px
Start display at page:

Download "PCI Pharmaceutical Consulting"

Transcription

1 PCI Pharmaceutical Consulting The Role of the QP: before & after Annex 16 Presented by: Karen Ginsbury For IFF, Denmark March 2016

2 Responsibility Authority

3 Responsibility Authority Having the duty to perform a task Being accountable for performing that task Having control over the performance of the task Without additional authorization The power or right to give orders, make decisions, and enforce obedience Within the framework of a company or organization

4 Responsibility YOUR duty to: Keep management informed Request and insist on appropriate resources Take action if authority is not granted Authority must be granted by: Owner Board of directors General manager / CEO Your boss if other than the above AND they must allow you to perform your responsibilities without interference and with appropriate resources

5 Responsibility vs Authority

6 The behaviors, beliefs and values characteristic of a particular group Culture is: Transmitted actively by defining: Mission Goals Metrics Transmitted passively and often subconsciously by behavior, body language, facial expressions and other actions

7 Better do it now Quality Quality System

8 What sort of Organization do you work in / with? active and visible support

9 Grumpy Cat What has changed? What is your most challenging issue?

10 What s Troubling Me

11 Certification by a QP and Batch Release: Annex 16 Issued October 2015 Effective 15 APRIL, 2016 Reason for update: SUPPLY CHAIN

12 Certification by a QP and Batch Release: Annex 16 Reason for update: SUPPLY CHAIN and FALSIFIED MEDICINES ACT, ICH Q8, 9, 10

13 Let s look at Annex 16 What jumps out?

14 Annex 16 Batch release pre-requisites Supplier qualification and falsified medicines directive API and excipients: Audits quality agreements CMOs: Production Packaging Other service providers

15 Annex 16 Batch release pre-requisites Validation and qualification (annex 15) in or out of scope? Computerized systems (annex 11) especially for batch release and inventory in or out of scope? Batch record review and data integrity

16 Annex 16 Batch release pre-requisites QP discretion CAPA, investigations And before any of that process mapping and risk assessment!

17 Risk Assessment for Excipients

18 What s Troubling the Inspector 2015 #1 Data integrity #2 Quality Culture (???) (attitude of most senior management??) leadership? #3 Quality Metrics #4 Drug Shortages #5 Supply chain and falsified medicines (although ties in with #1 closely)

19 GMP / GDP Inspectors Working Group

20 FDA Guidance Agenda 2015

21 What changes in last 12 months EU GMPs Part 1 Cap 3: Premises and Equipt Cap 5: Production Cap 8: Complaints, Recalls Effective: 01 Mar Mar Mar 2015 Annex 1 Annex 15 Annex 16 Annex 17 Concept paper on revision 01 Oct April 2016 Draft out

22 3 Premises and Equipment 3.6 as part of improved guidance on prevention of cross-contamination involving Cap 5

23 5 - Production

24 8 Complaints, Quality Defects and Product Recalls

25 Annex 15 Validation

26 Annex 17: Real Time Release Testing RTRT 26

27 Other US GMPs: 21CFR parts 210, 211, part 11 and part 820 FDA guidances: Draft guidance on quality metrics Quality system guidance vs ICH Q8, 9, 10 Process validation guidance Contract Manufacture

28 Other MHRA Compliance Report program and FDA on quality metrics WHO Guidances PIC/s Guidances USP, European Pharmacopoeia Pulling together the threads and staying updated

29 Hot Topics Data Integrity

30 Data Integrity does your company have a data governance policy?

31 What is Quality Meeting requirements all of them all the time and that means defining the requirements Annex 16 defines requirements for batch certification and release

32 Waivers the act of intentionally [and voluntarily] relinquishing or abandoning a known right, claim, or privilege So a planned deviation or temporary change or special release is a waiver of quality which is meeting requirements (all of them all the time)

33 Have you Heard About ISO 9001:2015?

34 Product control What is the difference Process control

35 Product vs Process Control Product Is controlled at the end of the process and you can do nothing about it you have already made the quality so you test and if it is ok release and if it is not ok you SHOULD reject but you probably get into an OOS fight Process Is controlled through understanding where the variability is and controlling critical process parameters such that all three cakes come out the same even when baked by three different students in three different ovens

36 My bread is fresh and tasty Quality control: the process of producing the product (or service) with the intent of eliminating problems that might result in defects The use of techniques and activities to achieve, sustain and improve the quality of a product

37 Where does QP Responsibility Fit? Certification and Release 37

38 CPPs and CQAs (Critical) Quality Attribute (CQA): A physical, chemical, biological or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality [= safety, efficacy, performance] (Critical) Process Parameter (CPP): A process parameter whose variability has an impact on a critical quality attribute and therefore should be monitored or controlled to ensure the process produces the desired quality 38

39 I Chart Observation I Chart Observation I Chart Observation I Chart Observation I Chart Observation I Chart Observation UCL= _ X=99.63 LCL=87.71 UCL= _ X=97.94 LCL=83.23 UCL= _ X=97.94 LCL=83.23 UCL= _ X= LCL=88.05 UCL= _ X=99.63 LCL=87.71 UCL= _ X=98.76 LCL=86.35 CPPs affect CQAs: Reliable / Predictable Known variation / Reduce Variation I N P U T S (X) Individual Value People Equipment Individual Value Measurement Individual Value Individual Value Process y = ƒ(x) Inputs to the process control variability of the Output y Individual Value OUTPUT Materials Individual Value Individual Value I Chart Observation UCL= _ X=99.95 LCL=85.72 Environment Adapted from slide by Moheb Naser, When at FDA 39 39

40 George Bernard Shaw The only man I know who behaves sensibly is my tailor - he takes my measurements anew each time he sees me. The rest go on with their old measurements and expect me to fit them

41 FDA Metrics

42 FDA Optional Metrics Related to Quality Culture and Process Capability/Performance

43 Optional metric #2

44 Optional metric #2

45 Optional metric #3

46 What Quality Data Would Be Reported

47 What Quality Data Would Be Reported

48 Measurement is the basis of the Quality Process What do we measure What could we measure What should we measure What can we measure

49 Data Collection Plans (Protocols) What data NEEDS to be collected (if all data is important then none is important) HOW should it be collected? HOW should it be analyzed? HOW should it be presented? And by who and to whom? 49

50 How many metrics BE CAREFUL if everything is important then nothing is important

51 About Measurement Measurement is the first step that leads to control and eventually to improvement If you can t measure something, you can t understand it If you can t understand it, you can t control it If you can t control it, you can t improve it. H. James Harrington

52 Measureable But Meaningful If a measurement matters at all, it is because it must have some conceivable effect on decisions and behavior If we can't identify a decision that could be affected by a proposed measurement and how it could change those decisions, then the measurement simply has no value Douglas W. Hubbard, How to Measure Anything: Finding the Value of Intangibles in Business

53 Data Collection Plans Who decides what data to collect? How do they make that decision? How do they COMMUNICATE the decision? (what are the tools) How do they educate for compliance with the data collection plan?

54 The toolbox Fabulous 14 Tools Process flow diagram Cause and effect (fishbone) Pareto chart Check sheets Location diagrams Tally count Time plot Scatter diagram Histogram Stem and Leaf Box and Whisper plot Regression analysis Control Chart Conformance chart

55 Dashboards Dashboards are reporting tools that consolidate and arrange numbers, metrics and sometimes scorecards on a single screen Usually tailored for a specific role Display metrics targeted for a single point of view or department

56 Dashboards

57 The Power of Walking the Floor Thoughts?

58 The Power of Walking the Floor You see but you do not observe Just stand and watch a production operation and ask questions about what you see Talk to operators and LISTEN to their comments You must understand the processes you are certifying

59 In Conclusion GMP isn t enough even if c Keep it Simple: Define requirements Use Risk Management to identify risks and prevent them from happening Monitor and improve in a PDCA cycle

60 In Conclusion Stay up to date Stay cool, calm and collected Ask for and make sure you get data and information in order to make informed decisions Have process maps and regularly audit or have links in the chain audited by people you trust Investigate and participate in significant deviations, changes and quality defects / complaints Refuse to be brushed aside with an it s ok Use RISK MANAGEMENT not just take risks

61 FIND ME AT: THANK YOU FOR PARTICIPATING

cgmp Update Presented by: Karen Ginsbury For IFF, Denmark November 2016

cgmp Update Presented by: Karen Ginsbury For IFF, Denmark November 2016 cgmp Update Presented by: Karen Ginsbury For IFF, Denmark November 2016 Trainer quiz 10 quickies Grumpy Cat Last IFF Update: March 2016 What has changed? What is your most challenging issues related to

More information

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016 New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017 Quality Systems Indian Pharmaceutical Alliance Advanced GMP Workshops 2017 Presented by Patrick Costello on November 2017 Principal Scientific Administrator Manufacturing & Quality Compliance An agency

More information

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8

More information

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil

More information

Quality Assessment & GMP Similarities & Differences

Quality Assessment & GMP Similarities & Differences Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences

More information

Regulatory Update. Paul Sexton. QP Forum

Regulatory Update. Paul Sexton. QP Forum Regulatory Update Paul Sexton QP Forum 16 th April, 2015 Content Updates on GMP Guidance Updates on EU Legislation Draft Ph Eur monograph on WFI including RO 2 Chapter 5 - Production Paragraphs 27 to 30

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics Objectives Review Quality Systems Audit Approach and cgmp fundamentals Logistical Audit Preparation

More information

A Comprehensive Approach to Find and Remediate Data Integrity Problems

A Comprehensive Approach to Find and Remediate Data Integrity Problems A Comprehensive Approach to Find and Remediate Data Integrity Problems June 14, 2017 Copyright 2017 QuintilesIMS. All rights reserved. What is data integrity? Whom does it apply to? Definitions matter

More information

Self-Inspection and its potential benefits via ICH Q9 & Q10

Self-Inspection and its potential benefits via ICH Q9 & Q10 Self-Inspection and its potential benefits via ICH Q9 & Q10 Kevin O Donnell, Ph.D. Senior Inspector & Market Compliance Manager Irish Medicines Board IMB Information Day October 23 rd, 2008 Slide 1 Topics

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7

More information

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

Enabling Improvement through the Product Lifecycle: Change Management within a PQS Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,

More information

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions

More information

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Introduction to EU Regulatory system and GMP Inspection system. The Qualified Person. DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Any views expressed may not necessarily

More information

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813

More information

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain Presented by: Karen Ginsbury For IFF 01 March, 2017 Pharma Supply Chain Manufacturer Wholesaler Raw Material Supply Production Transport Warehouse

More information

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing

More information

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance

Testo Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance Testo Expert Knowledge The GxP Dictionary 1st edition Definitions relating to GxP and Quality Assurance Note: Some of the information contained in this GxP Dictionary does not apply equally to all countries.

More information

FDA Quality Metrics Guidance

FDA Quality Metrics Guidance FDA Quality Metrics Guidance Marlène García Swider, Ph.D., CQM, CSSBB Institute of Validation Technology Quality Metrics Conference February 22 24, 2016 Coronado Island, San Diego, CA Personal Claim This

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW 1.0 INTRODUCTION: The purpose of this guidance is to communicate the expectation with regard to the conduct of Product Quality Review. Product Quality

More information

Quality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1

Quality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1 Quality Risk Management of the GDP Supply Chain Crowne Plaza Hotel, 25/2/2010 Dr Cormac Dalton Inspector Date 22-Feb-10 Slide 1 Supply Chain Experiment Pharmaceutical excipient ordered 3 rd December 09

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

Quality Metrics: A Regulatory Perspective

Quality Metrics: A Regulatory Perspective Quality Metrics: A Regulatory Perspective By Tara Gooen Bizjak, MBSci CDER Office of Policy for Pharmaceutical Quality Presented By Dr. Ademola Daramola US FDA Office of International Programs Indian Pharmaceutical

More information

Overview sulla nuova guideline GDP

Overview sulla nuova guideline GDP AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

Quality Risk Management: Excipients

Quality Risk Management: Excipients Quality Risk Management: Excipients ExcipientFest 2012 Presented by: Londa Ritchey, M.S. Director, Supplier Qualification Global Quality Operations Pfizer, Inc. Agenda Regulatory Environment Material Quality

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit. FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis

More information

Risk Analysis: myths, confusions and real sense

Risk Analysis: myths, confusions and real sense Risk Analysis: myths, confusions and real sense Dr. Alexander Fedotov, Director of Invar-project Company, Moscow, Russia fedotov@invar-project.ru www.invar-project.ru 1. What is risk analysis? 2. GMP EU

More information

FDA s Draft Guidance Request for Quality Metrics: What All Drug and Biologics Manufacturers Need to Know June 2017

FDA s Draft Guidance Request for Quality Metrics: What All Drug and Biologics Manufacturers Need to Know June 2017 FDA s Draft Guidance Request for Quality Metrics: What All Drug and Biologics Manufacturers Need to Know June 2017 Discussion Topics Quality Concepts The Journey The Guidance Details Industry Responses

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Quality System Resourcing GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing

More information

Outsourcing - managing risks and opportunities over which you now have less control

Outsourcing - managing risks and opportunities over which you now have less control Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

Conducting Supplier Audits: Ensure Validation Compliance

Conducting Supplier Audits: Ensure Validation Compliance Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why

More information

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00 Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel

More information

Management System Hilton Olympia, London 13 th February 2013

Management System Hilton Olympia, London 13 th February 2013 14. Building A Robust Quality Management System Hilton Olympia, London 13 th February 2013 Calcott Consulting consultant to the pharmaceutical & biotechnology industry Presenter s note Please note, the

More information

GMP Track 1 Day 2 Session 1 Vendor Assurance

GMP Track 1 Day 2 Session 1 Vendor Assurance GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

Developing an Internal Quality Auditing Program

Developing an Internal Quality Auditing Program Developing an Internal Quality Auditing Program SeerPharma Pty Lt Capsig August 2009 1 Critical Success Factors Culture of Compliance Integrate quality systems and risk management principles Well defined

More information

Managing Quality in Pharmaceutical Industry Using Six Sigma. Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA

Managing Quality in Pharmaceutical Industry Using Six Sigma. Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA Managing Quality in Pharmaceutical Industry Using Six Sigma Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA Outlines Pharmaceutical Manufacturing Process and Drug Product Quality. Process Excellence Approach

More information

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018 PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 045-1 1 July 2018 GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

Materials Management Traceability, CEPs and managing non-conforming sites

Materials Management Traceability, CEPs and managing non-conforming sites Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain

More information

CV Mads Friis Sørensen, Elsdyrvej 18, 4623 Lille Skensved

CV Mads Friis Sørensen, Elsdyrvej 18, 4623 Lille Skensved Employment, Company and Position Jan 2007 present CV Pharmac, Founder and Senior GMP Consultant, See. Summary General consultancy for the pharmaceutical industry within the area s of Quality Assurance,

More information

Metrics in Microbiology Monitoring Practices

Metrics in Microbiology Monitoring Practices Metrics in Microbiology Monitoring Practices Crystal Booth, M.M. Masters of Microbiology from North Carolina State University Former Associate Director of Microbiology at Novartis Metrics in Microbiology

More information

Journal home page: RESEARCH ARTICLE

Journal home page:  RESEARCH ARTICLE Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;

More information

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB GMP for ATMP Advanced Therapy Medicinal Products 2018 Key2Compliance AB 1 Content Background and regualtory requirements GMP Walkthrough Quality Risk Management 2018 Key2Compliance AB 2 Background and

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson

Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson Senior Management Consultant Agenda Introduction A state-of

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC) Overview of USFDA Drug Regulatory Requirements Pharmaceutical Quality and Facility Inspections (GMP) Session II 19 February 2014 Casablanca, Morocco GMP The Other Side of Chemistry, Manufacturing & Controls

More information

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND

More information

White paper Audits in automated production

White paper Audits in automated production White paper Audits in automated production data management for automation Introduction: Audits in automated production In the field of production management, audits have become an important tool for analysing

More information

Handling OOS, OOT and Unexpected Results. Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017

Handling OOS, OOT and Unexpected Results. Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017 Handling OOS, OOT and Unexpected Results Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017 What is an OOS What is an OOT What is an Unusual, Questionable, Atypical Result Objective:

More information

EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016

EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016 EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems Jan Thomsen Warsaw, November 15 th, 2016 2 Content Emprove - An Introduction Emprove for Raw and Starting Materials

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer

Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer Maklakova Olga, Quality director Kazan, 2018 Facilities 1 solid formsworkshop 1 semi-solid formsworkshop

More information

Quality Management (PQM01) Chapter 04 - Quality Control

Quality Management (PQM01) Chapter 04 - Quality Control Quality Management (PQM01) Chapter 04 - Quality Control Slide 1 Slide 2 Involves monitoring specific project results to determine if they comply with relevant quality standards, and identifying ways to

More information

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) ASQ Northeast Pharmaceutical GMP/Quality Conference January

More information

Data Integrity: Points of view from a regulator

Data Integrity: Points of view from a regulator Data Integrity: Points of view from a regulator David Churchward, Expert GMP Inspector, MHRA UK Copenhagen, Denmark 23-26 November 2015 1 Introduction Important daily decisions regarding safety, efficacy

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York

How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York June 13, 2017 IVT Microbiology Week 1 Presentation Overview Rationale

More information

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department

More information

T H E P R O P O S A L F O R T H E Y E A R

T H E P R O P O S A L F O R T H E Y E A R Training T H E P R O P O S A L F O R T H E Y E A R 2 0 1 9 Our GMP courses combine a convenient format with an effective, interactive learning experience. To maximize and customize your professional development.

More information

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013. GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively

More information

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments

More information

Excipient GMP GDP Certification Project. Presentation to FECC Seminar Brussels 19 th March 2009 Dr Iain Moore Chair GMP Committee IPEC Europe

Excipient GMP GDP Certification Project. Presentation to FECC Seminar Brussels 19 th March 2009 Dr Iain Moore Chair GMP Committee IPEC Europe Excipient GMP GDP Certification Project Presentation to FECC Seminar Brussels 19 th March 2009 Dr Iain Moore Chair GMP Committee IPEC Europe Excipient GMP GDP and Certification 1. Basis for Project 2.

More information

Scientific & Risk Based Compliance

Scientific & Risk Based Compliance www.qualitybydesign.es Scientific & Risk Based Compliance QbD Pharmaceutical Services S.L About us Mission Flexibility QbD Pharmaceutical Services S.L delivers high added-value services and specialised

More information

Regulatory Compliance Inspections at MAH Offices: Implications for Manufacturers

Regulatory Compliance Inspections at MAH Offices: Implications for Manufacturers Regulatory Compliance Inspections at MAH Offices: Implications for Manufacturers Kevin O Donnell, Ph.D. Market Compliance Manager GMP & Market Compliance Info Day September 2012 Slide 1 What are Regulatory

More information

Supplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015

Supplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015 Supplier Qualification and Regulatory Compliance in International Biopharm Logistics November 19 th, Copenhagen, 2015 Pharmaceutical Quality Management Partner Selection and Qualification Outsourcing and

More information

GMP for ATMP should be a document annexed to standard GMP (a new Annex) and not a stand-alone document.

GMP for ATMP should be a document annexed to standard GMP (a new Annex) and not a stand-alone document. Leem comments on Commission proposal for Good Manufacturing Practice for Advanced Therapy Medicinal Products 1. General comments Line number(s) of the relevant text General comment

More information

Online Student Guide Types of Control Charts

Online Student Guide Types of Control Charts Online Student Guide Types of Control Charts OpusWorks 2016, All Rights Reserved 1 Table of Contents LEARNING OBJECTIVES... 4 INTRODUCTION... 4 DETECTION VS. PREVENTION... 5 CONTROL CHART UTILIZATION...

More information

Supplier Assurance Program. CBE Pty Ltd

Supplier Assurance Program. CBE Pty Ltd Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.

More information

CBER Expectations Regarding Contract Manufacturing

CBER Expectations Regarding Contract Manufacturing CBER Expectations Regarding Contract Manufacturing LCDR Qiao Bobo, Ph.D. FDA/CBER/OCBQ/DMPQ CASSS CMC Strategy Forum Summer 2014 Outline 2 Types of Cooperative Manufacturing Arrangements CBER Expectations

More information

MHRA S NORMAN GRAY ON ANNEX 15 REVISION AND VALIDATION INSPECTION FINDINGS

MHRA S NORMAN GRAY ON ANNEX 15 REVISION AND VALIDATION INSPECTION FINDINGS MHRA S NORMAN GRAY ON ANNEX 15 REVISION AND VALIDATION INSPECTION FINDINGS At the ISPE/PQRI Process Validation Conference in Silver Spring, MD in early October, MHRA Senior GMP Inspector Norman Gray discussed:

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION 1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS

More information

MASTER PLANNING FOR VALIDATION

MASTER PLANNING FOR VALIDATION MASTER PLANNING FOR VALIDATION By: Gamal Amer, Ph.D. Principal, Premier Compliance Services, Inc. 1 Process Validation: General Principles and Practices Guidance to industry issued by the FDA in January

More information

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd. Incremental GMPs Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, 2017 1/55 Sound Science Good Development Practice Traceability R&D Tox I II III IV What You Need Here Can t be generated here

More information

Comments from: 1. General comments. International Plasma Fractionation Association (IPFA) Our ref. IP

Comments from: 1. General comments. International Plasma Fractionation Association (IPFA) Our ref. IP Submission of comments on Commission proposal for Good Manufacturing Practice for Advanced Therapy Medicinal Products Comments from: Name of organisation or individual International

More information

BATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT

BATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT BATCH DISPOSITION REGULATION Jakarta 14 DECEMBER 2017 Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT Definition Batch disposition = product disposition = lot disposition The documented control, status

More information

Strategies to Revise Quality Policy and Quality Objectives. Eileen Cortes February 22, 2017

Strategies to Revise Quality Policy and Quality Objectives. Eileen Cortes February 22, 2017 Strategies to Revise Quality Policy and Quality Objectives Eileen Cortes February 22, 2017 Agenda Elements of Compliance Quality Policy Outline Quality Strategy and Objectives Case Study Open Discussion

More information

Culture & the QP. Frank Hallinan Annual QP Forum 16 April 2015.

Culture & the QP. Frank Hallinan Annual QP Forum 16 April 2015. Culture & the QP. Frank Hallinan. 2015 Annual QP Forum 16 April 2015. The Big Picture: NOT about Handel, Heaney or, Hurling! What is responsibility of QP? Certify individual batches of a medicine. Assure

More information